Abbott Laboratories CDR (ABT)
NEO
Closed
Aug 25, 2026
Day's Range
20.2952 wk Range
14.46Overview - ABT - Abbott Laboratories CDR
Key Statistics
Valuation
Enterprise Value
281.01B
P/E (Trailing)
‪14.28‬
PEG Ratio
‪-0.29‬
Price / Sales (TTM)
‪6.37‬
Price / Book
‪0.71‬
EV / EBITDA
‪23.36‬
Profitability
Profit Margin
‪31.88%‬
Operating Margin
‪18.09%‬
Return on Assets
‪6.37%‬
Return on Equity
‪30.64%‬
Ownership
Shares Outstanding
13.37B
Float
1.72B
Price stats
Beta
‪0.74‬
50-Day Avg
‪22.45‬
200-Day Avg
‪23.28‬
Dividends
Payout Ratio
‪0.00%‬
Frequency
Quarterly
Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - ABT - Abbott Laboratories CDR
Profile Summary - ABT - Abbott Laboratories CDR
About
Abbott Laboratories CDR is a Canadian Depositary Receipt providing investors with exposure to Abbott Laboratories, a global leader in healthcare product discovery, development, manufacturing, and sales. The company operates across four key segments: Established Pharmaceutical Products, offering branded generics for…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
